human c1 esterase inhibitor
PolandDrugs containing this active substance
-
The medicine is used to treat and prevent the occurrence of swelling (edema) during procedures in individuals suffering from hereditary angioedema type I and II.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 450-625 IU/ml ATC: B02AB03
Manufacturer: CSL Behring GmbH
-
The medicinal product is used for the prevention of recurrent attacks of hereditary angioedema (HAE) in adolescents and adults.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 2000 j.m. ATC: B06AC01
Manufacturer: CSL Behring GmbH
-
The medicine is used for protection against recurrent attacks of hereditary angioedema (HAE) in adolescents and adults.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 3000 j.m. ATC: B06AC01
Manufacturer: CSL Behring GmbH
-
The medicine is used to treat and prevent the occurrence of swelling (edema) during procedures in people suffering from hereditary angioedema type I and II (HAE).
Form: solution for injection or infusion, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 40.0 - 62.5 J/ml ATC: B06AC01
Manufacturer: CSL Behring GmbH